United Kingdom Pharmaceuticals

Nuformix PLC (NFX)

Track

Track

Ticker: NFX Exchange: LSE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Nuformix PLC. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Dan Gooding Executive Director Executive Director
Transaction date
Purchase
Price
231.06
Quantity 5,758
Value £1,435,934
Maddy Kennedy Non-Executive Director Executive Director
Transaction date
Purchase
Price
228.78
Quantity 28,516
Value £1,481,679
Julian Gilbert Non-Executive Chairman Director
Transaction date
Purchase
Price
406.78
Quantity 45,402
Value £1,049,706
Dr Alastair Riddell Executive Chairman Director
Transaction date
Purchase
Price
0.01
Quantity 400,000
Value £4,700
Dr Alastair Riddell Chairman Director
Transaction date
Purchase
Price
0.00
Quantity 350,000
Value £47
Dr Alastair Riddell Chairman Director
Transaction date
Purchase
Price
0.01
Quantity 350,000
Value £4,725
David Joszef Tapolczay Non-Executive Chairman Director
Transaction date
Sale
Price
0.09
Quantity 650,000
Value £56,550
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-05 2024-11-05 B Purchase Dan Gooding

Executive Director

Executive Director
5,758
231.06
£1,435,934 		5,758 231.06 £1,435,934
2024-11-05 2024-11-05 B Purchase Maddy Kennedy

Non-Executive Director

Executive Director
28,516
228.78
£1,481,679 		28,516 228.78 £1,481,679
2024-11-05 2024-11-05 B Purchase Julian Gilbert

Non-Executive Chairman

Director
45,402
406.78
£1,049,706 		45,402 406.78 £1,049,706
2022-01-10 2022-01-10 B Purchase Dr Alastair Riddell

Executive Chairman

Director
400,000
0.01
£4,700 		400,000 0.01 £4,700
2021-09-16 2021-09-16 B Purchase Dr Alastair Riddell

Chairman

Director
350,000
0.00
£47 		350,000 0.00 £47
2021-09-16 2021-09-16 B Purchase Dr Alastair Riddell

Chairman

Director
350,000
0.01
£4,725 		350,000 0.01 £4,725
2020-02-05 2020-01-24 S Sale David Joszef Tapolczay

Non-Executive Chairman

Director
650,000
0.09
£56,550 		650,000 0.09 £56,550
Explore more

More insider trading research around Nuformix PLC

More insider trades in United Kingdom
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in Europe